SNRIs: Mechanism, Uses, Side Effects & Clinical Pearls
Mechanism
Block serotonin transporter (SERT) and norepinephrine transporter (NET) → ↑ synaptic 5-HT & NE → downstream neuroplasticity (BDNF, mTOR) → antidepressant/analgesic effect.
Agents & NE/5-HT Ratio
- Venlafaxine: Low dose = SSRI-like; ≥150 mg = SNRI
- Duloxetine: Balanced (1:10 NE:5-HT)
- Desvenlafaxine: Similar to venlafaxine
- Levomilnacipran: NE-preferring
- Milnacipran: NE-preferring (approved for fibromyalgia)
Indications
- MDD, GAD, panic disorder, social anxiety
- Chronic pain: diabetic neuropathy, fibromyalgia, chronic musculoskeletal (duloxetine, milnacipran)
- Stress urinary incontinence (duloxetine — ex-US)
Side Effects
- Nausea (transient, dose-related)
- Hypertension (dose-dependent, monitor)
- Sexual dysfunction, insomnia, diaphoresis, constipation
- Discontinuation syndrome (taper over 2–4 wks)
Onset
2–4 weeks for initial response; 6–8 weeks for full effect.
Prescription Medications - Related Articles
- Understanding and Evaluating Drug Interactions: A Comprehensive Guide
- Managing Opiate Tolerance: Understanding and Strategies
- Safely Open Glass Ampules: A Step-by-Step Guide
- Identifying Prescription Pills: A Guide to Numbers & Colors
- Erythromycin Ointment: Uses, Side Effects & Dosage
- Tamoxifen and Soy: Understanding the Interaction & Breast Cancer Risk
- Metadate CD vs. ER: Understanding the Differences & Benefits
